A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005)
Status:
Completed
Trial end date:
2010-06-21
Target enrollment:
Participant gender:
Summary
This was a 3-part study comparing the pharmacokinetics after administration of vaniprevir
(MK-7009) for participants with mild, moderate or severe hepatic insufficiency with healthy
matched control participants. The primary hypothesis is that the area under the curve (AUC)
(0 to infinity) of vaniprevir for participants with mild, moderate, or severe hepatic
insufficiency is similar to that observed in healthy matched controlled participants.